A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers

Clinical Trial ID NCT01316822

Rank	Title	Journal	Year	PubWeight™‹?›
1	Tackling the cancer stem cells - what challenges do they pose?	Nat Rev Drug Discov	2014	2.55
2	Immune cell promotion of metastasis.	Nat Rev Immunol	2015	2.15
3	Combination cancer immunotherapies tailored to the tumour microenvironment.	Nat Rev Clin Oncol	2015	1.54
4	Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.	Clin Dev Immunol	2011	1.41
5	Anti-tumour strategies aiming to target tumour-associated macrophages.	Immunology	2013	1.40
6	The genomics and genetics of endometrial cancer.	Adv Genomics Genet	2012	1.03
7	Human breast cancer cells educate macrophages toward the M2 activation status.	Breast Cancer Res	2015	0.97
8	Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia.	J Transl Med	2013	0.85
9	Emerging therapeutic targets in metastatic progression: A focus on breast cancer.	Pharmacol Ther	2016	0.79